Hansen Ree, A., Mælandsmo, G. M., Flatmark, K., Russnes, H. G., Gómez Castañeda, M., & Aas, E. (2022). Cost-effectiveness of molecularly matched off-label therapies for end-stage cancer – the MetAction precision medicine study. Acta Oncologica, 61(8), 955–962. https://doi.org/10.1080/0284186X.2022.2098053